Intravenous Immunomodulatory Nanoparticles Prevent Secondary Damage after Traumatic Brain Injury.

Area of Science:

• Neuroscience
• Immunology
• Biomedical Engineering

Background:

• Traumatic brain injury (TBI) triggers inflammatory responses involving monocyte/macrophage infiltration, leading to secondary damage.
• Current treatments for TBI often fail to address the critical early inflammatory cascade.
• Developing effective interventions to mitigate TBI-induced neuroinflammation is crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the efficacy and safety of intravenous immunomodulatory nanoparticles (IMPs) in mitigating TBI-induced secondary damage.
• To determine the dose-response relationship and therapeutic window for IMP administration post-TBI.
• To investigate the impact of IMPs on gene expression changes in neural and non-neural cells following TBI.

Main Methods:

• Administration of IMPs intravenously at varying doses and time points after TBI induction in a preclinical model.
• Assessment of behavioral deficits, lesion volume, and inflammatory cell infiltration.
• Single-cell RNA sequencing to analyze gene expression profiles in brain cells post-TBI and IMP treatment.

Main Results:

• IMP administration significantly reduced inflammatory cell infiltration, lesion size, and behavioral deficits.
• A dose-response relationship was observed, with a plateau at a well-tolerated dose.
• Effective therapeutic window of at least 6 hours post-TBI, with some benefit at 12 hours.
• IMPs ameliorated TBI-induced gene expression changes, including unexpected alterations in vascular smooth muscle cells.

Conclusions:

• Intravenous IMPs represent a promising, non-toxic therapeutic strategy for TBI, limiting secondary damage and improving outcomes.
• IMPs demonstrate a favorable safety profile and a broad therapeutic window, suitable for immediate post-injury administration.
• IMP treatment effectively modulates the neuroinflammatory response and prevents detrimental gene expression changes at the cellular level.